Showing results (401-410 of 1,045) with videos related to
Sort By:
Pageof 105
Personalized Medicine|October 27, 2018
Oxidized-LDL is a useful marker for predicting the very early coronary artery disease and cardiovascular outcomesXi Zhao, Hui-Wen Zhang, Rui-Xia Xu, et al.Personalized Medicine|October 27, 2018
Expression analysis of a panel of cancer-testis antigens in bladder cancerFatemeh Yazarlou, Vahid Kholghi-Oskooei, Mandana Afsharpad, et al.Personalized Medicine|March 22, 2019
Using clinical genomic sequencing to guide personalized cancer therapy in ChinaYuxian Bai, Guan Wang, Jinwang Wei, et al.Personalized Medicine|July 18, 2019
Consent for clinical genome sequencing: considerations from the Clinical Sequencing Exploratory Research ConsortiumJoon-Ho Yu, Paul S Appelbaum, Kyle B Brothers, et al.Personalized Medicine|March 17, 2021
PON1 polymorphisms can predict generalized anxiety and depressed mood in patients with multiple chemical sensitivityAlessio Mosca, Antonio Del Casale, Marina Borro, et al.Personalized Medicine|March 17, 2021
Maternal ancestry and hematological cancer risk: case-control study in an Argentinean populationMaría Belén Cerliani, Andrea Constanza Mayordomo, Anaclara Sanchez Dova, et al.Personalized Medicine|March 17, 2021
Family-level impact of genetic testing: integrating health economics and ethical, legal, and social implicationsHadley Stevens Smith, Amy L McGuire, Eve Wittenberg, et al.Personalized Medicine|November 11, 2021
miR-938rs2505901 T>C polymorphism increases Hirschsprung disease risk: a case-control study of Chinese childrenJun Zhong, Jiabin Liu, Yi Zheng, et al.Personalized Medicine|November 8, 2021
Therapeutic drug monitoring guided fluconazole therapy in a patient with cholangitis sepsisJana Duricova, Pavla Jadrnickova, Hana Brozmanova, et al.Personalized Medicine|February 4, 2022
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolitesLuana Mifsud Buhagiar, Marilyn Casha, Anton Grech, et al.Pageof 105